CSIR okays Bilcare’s nonClonableID tech to authenticate drugs

Our Bureau Updated - March 12, 2018 at 09:13 PM.

The Council of Scientific and Industrial Research under its New Millennium Indian Technology Leadership Initiative scheme has approved the implementation of the project “Customized adaptation of nonClonableID technology to establish authenticity of medical products” by Pune-based Bilcare Ltd.

Dr Praful Naik, Executive Director & Chief Scientific Officer, Bilcare, has been designated the principal investigator for the project.

With counterfeit drugs posing a major challenge in the pharmaceutical space, product accountability and traceability is critical for providing quality medical products. The issue covers not only detecting counterfeits or eliminating illegal duplicates, but also ensuring that medicine of genuine origin is consumed by the patients.

Published on May 30, 2012 11:21